Crunch Time For Aerie At EMA
An EU Marketing Recommendation Could Be In Store For New Glaucoma Treatment
Aerie is already exploring its pricing strategy for Roclanda as the European Medicines Agency this week decides whether the intraocular pressure treatment should be approved in Europe.
You may also be interested in...
The European Medicines Agency this week recommended that five new products be granted EU marketing approval.
Applications for the accelerated assessment of planned EU marketing applications for two drugs are being considered by the European Medicines Agency.
The sponsor of an ophthalmic formulation of bevacizumab is set to speak up for its marketing authorization application during a European Medicines Agency oral explanation meeting.